Asian American Medical Group Limited provides specialized medical services for liver diseases in Singapore, rest of Asia, and internationally. More Details
Excellent balance sheet and overvalued.
Share Price & News
How has Asian American Medical Group's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: Insufficient data to determine AJJ's volatility over the past 3 months.
Volatility Over Time: Insufficient data to determine AJJ's volatility change over the past year.
7 Day Return
1 Year Return
Return vs Industry: Insufficient data to determine how AJJ performed against the Australian Healthcare industry.
Return vs Market: Insufficient data to determine how AJJ performed against the Australian Market.
Long-Term Price Volatility Vs. Market
How volatile is Asian American Medical Group's share price compared to the market and industry in the last 5 years?
Simply Wall St News
Is Asian American Medical Group undervalued compared to its fair value and its price relative to the market?
Price to Book (PB) ratio
Share Price vs. Fair Value
Below Fair Value: Insufficient data to calculate AJJ's fair value to establish if it is undervalued.
Significantly Below Fair Value: Insufficient data to calculate AJJ's fair value to establish if it is undervalued.
Price To Earnings Ratio
PE vs Industry: AJJ is unprofitable, so we can't compare its PE Ratio to the Australian Healthcare industry average.
PE vs Market: AJJ is unprofitable, so we can't compare its PE Ratio to the Australian market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate AJJ's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: AJJ is good value based on its PB Ratio (1.3x) compared to the AU Healthcare industry average (1.7x).
How is Asian American Medical Group forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Healthcare industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Asian American Medical Group has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
How has Asian American Medical Group performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: AJJ is currently unprofitable.
Growing Profit Margin: AJJ is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: AJJ is unprofitable, and losses have increased over the past 5 years at a rate of 3.6% per year.
Accelerating Growth: Unable to compare AJJ's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: AJJ is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (25.5%).
Return on Equity
High ROE: AJJ has a negative Return on Equity (-29.73%), as it is currently unprofitable.
How is Asian American Medical Group's financial position?
Financial Position Analysis
Short Term Liabilities: AJJ's short term assets (SGD1.6M) do not cover its short term liabilities (SGD2.1M).
Long Term Liabilities: AJJ's short term assets (SGD1.6M) exceed its long term liabilities (SGD1.1M).
Debt to Equity History and Analysis
Debt Level: AJJ is debt free.
Reducing Debt: AJJ has not had any debt for past 5 years.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: AJJ has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: AJJ has sufficient cash runway for 1.3 years if free cash flow continues to reduce at historical rates of 9.5% each year.
What is Asian American Medical Group current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate AJJ's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate AJJ's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if AJJ's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if AJJ's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: AJJ is not paying a notable dividend for the Australian market.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of AJJ's dividend in 3 years as they are not forecast to pay a notable one for the Australian market.
How experienced are the management team and are they aligned to shareholders interests?
Average board tenure
Asian American Medical Group has no CEO, or we have no data on them.
Experienced Board: AJJ's board of directors are considered experienced (8 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Asian American Medical Group Limited's company bio, employee growth, exchange listings and data sources
- Name: Asian American Medical Group Limited
- Ticker: AJJ
- Exchange: ASX
- Founded: 1994
- Industry: Health Care Services
- Sector: Healthcare
- Market Cap: AU$11.824m
- Shares outstanding: 347.75m
- Website: https://www.aamg.co
Number of Employees
- Asian American Medical Group Limited
- Gleneagles Hospital
- Annexe Block No. 02-37
Asian American Medical Group Limited provides specialized medical services for liver diseases in Singapore, rest of Asia, and internationally. It operates through Liver, Multi-Speciality, Management and Co...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/06/25 08:23|
|End of Day Share Price||2021/06/24 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.